Drugs / Huaiqinhuang
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 0 | NCT04623866 Comparator | Nov 2020 → Aug 2021 | immunoglobulin A vasculitis | The Children's Hospital of Zhejiang University School of Medicine | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Huaiqinhuang | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04623866 ↗ |
| Known as | huaiqihuang | “Studies have shown that huaiqihuang treatment can reduce cytokines in children with purpura nephritis” NCT04623866 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Huaiqihuang granules are composed of Huaier fungus, Fructus lycii and Huangjing.” NCT04623866 ↗ |